Carmai Seto
Publications by Year
Research Areas
Mass Spectrometry Techniques and Applications, Analytical chemistry methods development, Pharmacogenetics and Drug Metabolism, Analytical Chemistry and Chromatography, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K(2008)470 cited
- → Discovery of a Potent and Selective Prostaglandin D2 Receptor Antagonist, [(3R)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid (MK-0524)(2007)170 cited
- → Microdosing Assessment to Evaluate Pharmacokinetics and Drug Metabolism in Rats Using Liquid Chromatography-Tandem Mass Spectrometry(2008)43 cited
- → β-Substituted Cyclohexanecarboxamide: A Nonpeptidic Framework for the Design of Potent Inhibitors of Cathepsin K(2006)36 cited
- → Low energy collisionally activated dissociation of Cu2+(glycine)(H2O), Cu2+(glycine)(H2O)2, Cu2+(glycine)2, and Cu2+(glycylglycine)2(1999)31 cited
- → The reactions of Cu2+(CH3CN)n (n = 2–4) and Cu2+(CH3CN)3(H2O) at low collision energy with neutral molecules in a triple sector quadrupole instrument(1998)29 cited
- → Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: Impacts of glutathione trapping and glucuronide conjugation on covalent binding(2007)28 cited
- → Development of generic liquid chromatography-mass spectrometry methods using experimental design(2002)28 cited
- → Detection of Covalent Adducts to Cytochrome P450 3A4 Using Liquid Chromatography Mass Spectrometry(2004)26 cited
- → The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor(2009)24 cited